Cost-effectiveness research on preventive interventions: A survey of the publications in 2008

European Journal of Public Health

Volumn 21, Issue 2, 2011, Pages 260-264

  Van Gils, Paul F ^a   Tariq, Luqman ^a   Verschuuren, Marieke ^a   Van Den Berg, Matthijs ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

burden of disease; economic evaluation; prevention

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; HEALTH PROMOTION; HUMAN; INFECTION CONTROL; LITERATURE; MEDLINE; PRIMARY PREVENTION; QUALITY ADJUSTED LIFE YEAR; RESEARCH; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASE CONTROL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH PROMOTION; HUMANS; PRIMARY PREVENTION; PUBMED; QUALITY-ADJUSTED LIFE YEARS; RESEARCH; REVIEW LITERATURE AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 79953220178     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckq069     Document Type: Article

References (14)

1. Hollander, AEMd, Hoeymans N, Melse JM, et al. Care for health. The 2006 Dutch Public Health Status and Forecasts Report. RIVM Rapport 2007; 270061003.
2. Drummond MF, Sculpher MJ, Torrance GW, Stoddart GL. Methods for economic evaluation of health care programmes, 3rd edn. Oxford: Oxford University Press, 2005.
3. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. [cited 2009 15-05]; 10th revision. [Available at: http://www.who.int/classifications/apps/icd/icd10online/, 2007.
4. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313:275-83. (Pubitemid 26254740)
5. OECD. PPPs and exchange rates. [cited 2009 15-05]; Available at: http://stats.oecd.org/Index.aspx?datasetcode=SNA-TABLE4#, 2009.
6. CBS. Consumentenprijsindices (CPI) alle huishoudens, 2006=100. [cited 2008 14 mei]; Available at: http://statline.cbs.nl/StatWeb/publication/?VW= T&DM=SLNL&PA=71311ned&D1=0-1,4-5&D2=0&D3=a&HD= 080514-1109&HDR=T&STB=G2, 2009.
7. Buxton MJ. Economic evaluation and decision making in the UK. Pharmacoeconomics 2006;24:1133-42. (Pubitemid 44683369)
8. Pomp M, Brouwer WB, Rutten FF. QALY-tijd; Nieuwe medische technologie, kosteneffectiviteit en richtlijnen. Den Haag: Centraal Planbureau, Report No.: 152, 2007.
9. van den Berg M, de Wit GA, Vijgen SM, et al. [Cost-effectiveness of prevention: opportunities for public health policy in the Netherlands]. Ned Tijdschr Geneeskd 2008;152:1329-34.
10. Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000;20:332-42. (Pubitemid 30479101)
11. World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization, 2008.
12. World Health Organization. Disease and injury regional estimates for 2004. Health statistics and health information systems. [cited 2009 02092009]; Available at: http://www.who.int/healthinfo/global-burden-disease/estimates- regional/en/index.html, 2004.
13. Baan CA, Schoemaker CG, Jacobs, van der Bruggen MAM, et al. Diabetes tot 2025. Preventie en zorg in samenhang. RIVM Rapport, 2009; 260322004.
14. van Gils P, van den Berg M, van Kranen H, de Wit AG. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening. Eur J Cancer 2009;45: 1554-9.